Experts Matter. Find Yours.
Connect for media, speaking, professional opportunities & more.
Sept. 25 is National Daughters Day, celebrating adult daughters often overlooked for their role in relationship with parents National Daughters Day is Sept. 25, an oft-overlooked holiday that has been around since 1932. But much like the holiday, adult daughters are often unnoticed for the important role they play in the lives of their parents. Allison M. Alford, Ph.D., clinical associate professor of business communication at Baylor University and co-host of the weekly podcast, “Hello Mother, Hello Daughter,” researches adult daughters and their “invisible labor” in maintaining the unity of a family. Adult daughters find themselves providing support, nurturing and much more in a socially and communicatively constructed, shaped and molded role that includes navigating, responding to and negotiating cultural and familial discourses. These behaviors occur throughout a daughter’s life and represent significant resources funneled toward her parents to maintain and nurture a relationship. Alford’s research on “daughtering” – the active way that daughters relate to and care for parents – is how she describes the work and effort that daughters provide their parents. “It’s that purposeful work that helps relationships flourish but often goes uncredited as work, even by daughters themselves, in part because the efforts are wrapped in misleading language and society hasn’t adopted a lexicon specifically for daughtering,” said Alford, who edited the book, “Constructing Motherhood and Daughterhood Across the Lifespan,” with research partner Michelle Miller-Day, Ph.D., of Chapman University in Orange County, California. Daughtering involves such “invisible labor” as planning and organizing family events, resolving conflicts, acting as a buffer with other family members, preparing for the future and more—with the intent of supporting important family relationships, Alford said. With dashes of “mental load” and “adulting,” thrown in the mix, adult children are engaging in effortful and intense relationship-building, from which they usually benefit in the form of familial support and love. Embracing National Daughters Day In recent years, social media has embraced National Daughters Day with parents posting loving tributes and sharing stories about their daughters, recognition that Alford encourages. “Adult daughters put a lot of effort into their families and recognizing their hard work with praise and affirmation shows that what they do matters. Every daughter would love to hear compliments on her daughtering,” Alford said, recommending that parents take time on Sept. 25 to acknowledge and thank their adult daughters for the care and time they give to the family. A few simple ways parents can acknowledge adult daughters: Call your daughter on the phone and tell her how much her efforts have meant to you, Create a social media tribute and share a picture of yourselves together over the years, Order takeout delivered to her house for dinner, or Call the grandkids and tell them a sweet story about their mom. Also on Sept. 25, Alford and Miller-Day will launch Season 2 of their weekly podcast, “Hello Mother, Hello Daughter,” which continues to explore what it means to be an adult daughter and how daughtering and mothering work together to create a harmonious family. This season, the hosts interview experts on adult mother-daughter relationship topics and share helpful resources that can enable positive family interactions. The podcast will be available everywhere you listen to podcasts. “Hello Mother, Hello Daughter” also is on social media on Instagram and Facebook.
Covering King Charles? Our Expert can Help
It's news that has shocked the world and has citizens across Britain and the Commonwealth as well loyal watchers of the British monarchy in deep concern. This week, King Charles was diagnosed with cancer. News was released Monday in a statement from the palalce. This news will raise many questions both in the UK and abroad. Will his medical condition make him consider stepping down? Is William ready to be King? Is there still a time, place and relevance for Royals in these modern times? If you're covering - let our experts help. Dr. Glen Duerr is a citizen of three countries. He was born in the United Kingdom, moved to Canada as a teenager, and then to the United States to obtain his Ph.D. His teaching and research interests comparative politics and international relations theory. Dr. Duerr is available to speak to media regarding this topic– simply click on his icon to arrange an interview.
Exploring the Depths: How AI is Revolutionizing Seafloor Research
In recent years, there has been a significant shift in the way seafloor research is conducted, all thanks to the groundbreaking advancements in artificial intelligence (AI) technology. The depths of our oceans have always been a mystery, but with the use of AI, scientists and researchers are now able to explore and uncover the hidden secrets that lie beneath the surface. With funding from the Department of Defense, University of Delaware oceanographer Art Trembanis and others are are using artificial intelligence and machine learning to analyze seafloor data from the Mid-Atlantic Ocean. The goal is to develop robust machine-learning methods that can accurately and reliably detect objects in seafloor data. “You can fire up your phone and type dog, boat or bow tie into a search engine, and it's going to search for and find all those things. Why? Because there are huge datasets of annotated images for that,” he said. “You don't have that same repository for things like subway car, mine, unexploded ordnance, pipeline, shipwreck, seafloor ripples, and we are working to develop just such a repository for seabed intelligence.” Trembanis is able to talk about this research and the impact it could have on our day to day lives. He can be contacted by clicking his profile. “You have commercial companies that are trying to track pipelines, thinking about where power cables will go or offshore wind farms, or figuring out where to find sand to put on our beaches,” said Trembanis. “All of this requires knowledge about the seafloor. Leveraging deep learning and AI and making it ubiquitous in its applications can serve many industries, audiences and agencies with the same methodology to help us go from complex data to actionable intelligence.” He has appeared in The Economic Times, Technical.ly and Gizmodo.
Since 2022, the U.S. Food and Drug Administration has been actively urging consumers to avoid purchasing or consuming tianeptine -- a synthetic drug commonly called "gas station heroin" that can mimic the actions of opioids like fentanyl. Now, the FDA is upping the urgency of it's warnings as vendors continue to market the drug as a so-called "dietary supplement." UConn's C. Michael White, a Distinguished Professor of Pharmacy Practice, spoke with The Conversation about the problem with tianeptine in a must-read Q-and-A: What is tianeptine and why is it risky? Tianeptine stimulates the same receptors as well-known opioids such as fentanyl, heroin and morphine. When these drugs make their way from the blood to the brain, they bind to the “mu” type opioid receptor that triggers the sought-after pain relief and euphoria of those drugs as well as the dangerous effects like slowed or stopped breathing. High doses of tianeptine can bring euphoric effects similar to heroin and can also bring about the dissociative effect – the perception of your mind being disconnected from your surroundings and body – that is reminiscent of ketamine, an anesthetic that has a role in treating post-traumatic stress disorder and depression but has also commonly been abused as a street drug. Products containing tianeptine are often called “legal high drugs” – sometimes dubbed “gas station drugs” – a term used for all non-FDA-approved synthetic drugs that are sold casually in gas stations, online and elsewhere. What are the major adverse effects that people can experience? Data from clinical trials, case reports and poison control centers shows that tianeptine commonly induces agitation. This is typically accompanied by a fast heart rate and high blood pressure, confusion, nightmares, drowsiness, dry mouth and nausea, among other conditions. The most serious adverse events are slowed or stopped breathing, coma, heart arrhythmia and death. When long-term users try to stop tianeptine use, they often experience withdrawal symptoms reminiscent of opioid withdrawal. Consumers need to be aware that products containing tianeptine may not adhere to good manufacturing practices. This means they could contain lead or have other heavy metal contamination or be contaminated by microorganisms such as salmonella or mold. They could also contain other drug ingredients that are not disclosed. Knowingly or unknowingly combining active ingredients can increase the risk of adverse events. Additionally, the amount of the active ingredient contained in the product can vary widely, even with the same manufacturer. So past use does not guarantee that using the same amount will provide the same effect. How are these drugs sold in the US if they are not FDA-approved? If a drug product is not FDA-approved for prescription or over-the-counter-use, it is the Drug Enforcement Agency that is responsible for controlling market access. Before the DEA can ban an active ingredient in a drug product, it must be designated Schedule I, meaning the drug has no legitimate medical purpose and has high abuse potential. Manufacturers do not have to alert the DEA before selling their products to U.S. citizens. This means the DEA must detect an issue, identify the products causing the issue, identify the active ingredients in the product in question and do a full scientific review before designating it as Schedule I. Tianeptine came to market masquerading as a dietary supplement in gas stations and smoke shops, even though it is a synthetic compound. Tianeptine is also sold online allegedly for research purposes and not for human consumption. Tianeptine is undergoing clinical trials for the treatment of pain and depression, but sellers do nothing to make this type of labeling clear to consumers or to restrict purchases to researchers. What can people do to protect themselves and their families? Non-FDA-approved products containing synthetic drugs are very risky to use and should be avoided. FDA-approved drugs are available by a prescription from a health professional or over the counter with active ingredients on an approved list. If someone in a gas station, smoke shop or over the internet touts the benefits of a non-FDA-approved drug product – for pain or anxiety relief, to increase energy or for a buzz – be aware. It could be dangerous the first time you use it, but using it successfully once also doesn’t mean the experience will be the same the next time, and continued use can cause addiction. If a product is being sold “not for human consumption” or “for research purposes only,” you are at a high risk if you take it. Before you take any dietary supplement, make sure you check the active ingredient to be sure that it is, in fact, a natural product and not a synthetic chemical. If someone you know has bags with unmarked powder, a product labeled for research use or not for human consumption, or tablets or capsules not in standard drug bottles, that is a sign of a potentially dangerous situation. Standard drug tests sold over the counter are not designed to pick up tianeptine. One of the main reasons that people use these alternative substances of abuse over regular opioids, cannabis or amphetamines is that they are much harder to detect through work- or at-home drug screens by parents, schools, employers, probation officers and so on. If the DEA is not responding to emerging threats quickly enough, individual states can also act to ban sales of dangerous active ingredients in products. As of January 2024, at least 12 states have banned the sale of tianeptine, according to the FDA, although people in those states can still illegally procure it from the internet. So contacting your state legislators could be a place to start exercising your power to help prevent the harms from these products. This is an important piece, and if you are looking to know about tianeptine and the threat it poses to consumers in America, then let us help. Dr. C. Michael White is an expert in the areas of comparative effectiveness and preventing adverse events from drugs, devices, dietary supplements, and illicit substances. Dr. White is available to speak with media -- click on his icon now to arrange an interview today.
Research: Add space salad to the risks astronauts face
University of Delaware researchers grew lettuce under conditions that imitated the weightless environment aboard the International Space Station and found those plants were actually more prone to infections from Salmonella. It’s been more than three years since the National Aeronautics and Space Administration made space-grown lettuce an item on the menu for astronauts aboard the International Space Station. Alongside their space diet staples of flour tortillas and powdered coffee, astronauts can munch on a salad, grown from control chambers aboard the ISS that account for the ideal temperature, amount of water and light that plants need to mature. But as the UD researchers discovered, there is a problem. The International Space Station has a lot of pathogenic bacteria and fungi. Many of these disease-causing microbes at the ISS are very aggressive and can easily colonize the tissue of lettuce and other plants. Once people eat lettuce that’s been overrun by E. coli or Salmonella, they can get sick. With billions of dollars poured into space exploration each year by NASA and private companies like SpaceX, some researchers are concerned that a foodborne illness outbreak aboard the International Space Station could derail a mission. In the new study by UD's team, published in Scientific Reports and in npj Microgravity, researchers grew lettuce in a weightless environment similar to that found at the International Space Station. Plants are masters of sensing gravity, and they use roots to find it. The plants grown at UD were exposed to simulated microgravity by rotation. The researchers found those plants under the manufactured microgravity were actually more prone to infections from Salmonella, a human pathogen. Stomata, the tiny pores in leaves and stems that plants use to breathe, normally close to defend a plant when it senses a stressor, like bacteria, nearby, said Noah Totsline, an alumnus of UD’s Department of Plant and Soil Sciences who finished his graduate program in December. When the researchers added bacteria to lettuce under their microgravity simulation, they found the leafy greens opened their stomata wide instead of closing them. “The fact that they were remaining open when we were presenting them with what would appear to be a stress was really unexpected,” Totsline said. Totsline, the lead author of both papers, worked with plant biology professor Harsh Bais as well as microbial food safety professor Kali Kniel and Chandran Sabanayagam of the Delaware Biotechnology Institute. The research team used a device called a clinostat to rotate plants at the speed of a rotisserie chicken on a spinner. “In effect, the plant would not know which way was up or down,” Totsline said. “We were kind of confusing their response to gravity.” Additionally, Bais and other UD researchers have shown the usage of a helper bacteria called B. subtilis UD1022 in promoting plant growth and fitness against pathogens or other stressors such as drought. They added the UD1022 to the microgravity simulation that on Earth can protect plants against Salmonella, thinking it might help the plants fend off Salmonella in microgravity. Instead, they found the bacterium actually failed to protect plants in space-like conditions, which could stem from the bacteria’s inability to trigger a biochemical response that would force a plant to close its stomata. “The failure of UD1022 to close stomata under simulated microgravity is both surprising and interesting and opens another can of worms,” Bais said. “I suspect the ability of UD1022 to negate the stomata closure under microgravity simulation may overwhelm the plant and make the plant and UD1022 unable to communicate with each other, helping Salmonella invade a plant.” To contact researchers from the team, visit the profiles for Bais or Kniel and click on the contact button.
Aston University AI project aims to make international health data sharing easier
Project to improve sharing data while complying with general data protection regulation (GDPR) guidelines Aston Institute of Photonic Technologies awarded almost £300k to work on European-wide project Will develop secure data sharing system to allow access to large sets of multi-source health data via tailor-made AI tools. Aston University is to explore the use of AI to improve sharing health data internationally. Dr Sergei Sokolovski of the University’s Aston Institute of Photonic Technologies has been awarded €317,500 to work on a European-wide project. Called BETTER (Better real-world health data distributed analytics research platform) the spans16 academic, medical and industrial partners. Although data-driven medicine is currently used to improve diagnosis, treatment and medical research ethical, legal and privacy issues can prevent sharing and centralising data for analysis. The research at Aston University’s involvement in the BETTER project aims to overcome these challenges so health data can be shared across national borders while fully complying with the general data protection regulation (GDPR) guidelines. Dr Sergei Sokolovski will lead the development of a secure data sharing system which will allow access to large sets of multi-source health data via tailor-made AI tools. Scientists and healthcare professionals will be able to compare, integrate and analyse data securely at a lower cost than current methods to improve people’s health. The BETTER project will focus on three health conditions; childhood learning disabilities, inherited degenerative retina diseases and autism, involving seven medical centres across the European Union and beyond. Dr Sergei Sokolovski said: “Data protection regulations prohibit data centralisation for analysis purposes because of privacy risks like the accidental disclosure of personal data to third parties. “Therefore, to enable health data sharing across national borders and to fully comply with GDPR guidelines this project proposes a robust decentralised infrastructure which will empower researchers, innovators and healthcare professionals to exploit the full potential of larger sets of multi-source health data. “As healthcare continues to evolve in an increasingly data-driven world projects like BETTER offer promising solutions to the challenges of health data sharing, research collaboration, and ultimately, improving the well-being of citizens worldwide. “The collaboration between multiple stakeholders, including medical centres, researchers, and innovators, highlights the importance of interdisciplinary efforts in addressing these complex issues.” The research will last 42 months. ENDS Better Real-World Health-Data Distributed Analytics Research Platform, Grant agreement 101136262 https://www.better-health-project.eu/ Research Universities taking part are: Aston University, Klinikum der Universitaet zu Koeln, Universiteit Maastricht, Universitat Politecnica de Valencia, Universitetet i Tromsoe, About Aston University Founded in 1895 and a university since 1966, Aston University is a long-established university led by its three main beneficiary groups – students, business and the professions, and the West Midlands region and wider society. Located in Birmingham at the heart of a vibrant city, the campus houses all the University’s academic, social and accommodation facilities for our students. Professor Aleks Subic is the Vice-Chancellor & Chief Executive. In 2022 Aston University was ranked in the top 25 of the Guardian University Guide, based on measures including entry standards, student satisfaction, research quality and graduate prospects. The Aston Business School MBA programme was ranked in the top 100 in the world in the Economist MBA 2021 ranking. For media inquiries in relation to this release, contact Nicola Jones, Press and Communications Manager, on (+44) 7825 342091 or email: n.jones6@aston.ac.uk
Image shows how tiny water channels control how water enters and exits cells through their membranes The Aston Institute for Membrane Excellence (AIME) will be set up with a £10m grant from Research England AIME will be led by Professor Roslyn Bill from Biosciences and Professor Paul Topham from Chemical Engineering and Applied Chemistry The globally unique institute will use biomimetic polymer membranes for applications such as water purification and drug development Aston University will establish the Aston Institute for Membrane Excellence (AIME), a globally unique, cross-disciplinary institute to develop novel biomimetic membranes, after receiving a major grant of £10m from Research England. AIME will be led by Professor Roslyn Bill, from the School of Biosciences, with co-lead Professor Paul Topham from the department of Chemical Engineering and Applied Chemistry (CEAC). Membranes, both biological and synthetic, are hugely important in many sectors. For example, the world’s top ten selling human medicines all target proteins in biological membranes, while synthetic polymer membranes are used in the US$100bn/year water purification industry. The team behind AIME believes that the full potential of membranes will only be realised by an interdisciplinary group spanning biology, physics and chemistry that can investigate membranes holistically. Professor Bill, a European Research Council (ERC) Advanced grantee leads Aston Membrane Proteins and Lipids (AMPL) research centre of excellence that studies the structure and function of membrane proteins and associated lipids. Professor Topham leads Aston Polymer Research Group (APRG), which investigates the nanoscale behaviour of block copolymers (a type of polymer with a structure made of more than one type of polymer molecule) and polymer technologies for membranes. AMPL and APRG have already begun collaborative research and AIME will bring together the complementary expertise of both research clusters into one institute. AIME will initially comprise the eight researchers from AMPL and APRG. Alongside the co-leads Professor Bill and Professor Topham, will be Dr Alan Goddard, Professor Andrew Devitt, Professor Corinne Spickett, Dr Alice Rothnie, Dr Matt Derry and Dr Alfred Fernandez. It plans to recruit three further academics, six tenure-track research fellows, three postdoctoral research assistants (PDRAs), six PhD students, a research technician and a business development manager. Importantly, AIME will work with many existing Aston University colleagues to build a comprehensive research community focused on all aspects of membrane science. The new AIME team will focus on the development of bioinspired, highly selective polymer structures for applications in water purification and waste remediation, nanoparticles loaded with therapeutic molecules to treat disorders ranging from chronic wounds to neurological injuries, and the purification of individual membrane proteins with polymers to study them as drug targets. The vision is for AIME to become a ‘one-stop shop’ for interdisciplinary, translational membrane research through its facilities access and expertise, ideally located in the heart of the country. Professor Bill said: “The creation of AIME is ground-breaking. Together with Aston’s investment, E3 funding will deliver a step-change in scale and the rate at which we can grow capacity. We will address intractable scientific challenges in health, disease, and biotechnology, combining our world-class expertise in polymer chemistry and membrane biology to study membranes holistically. The excellence of our science, alongside recent growth in collaborative successes means we have a unique opportunity to deliver AIME’s ambitious and inclusive vision.” Professor Topham said: “We are really excited by this fantastic opportunity to work more closely with our expert colleagues in Biosciences to create advanced technology to address real world problems. From our side, we are interested in molecular engineering, where we control the molecular structure of new materials to manipulate their properties to do the things that we want! Moreover, we are passionate about a fully sustainable future for our planet, and this investment will enable us to develop technological solutions in a sustainable or ‘green’ way.” Professor Aleks Subic, Vice-Chancellor and Chief Executive of Aston University, says: “Our new Aston Institute for Membrane Excellence (AIME) will be a regional, national, and international research leader in membrane science, driving game-changing research and innovation that will produce a pipeline of high-quality research outcomes leading to socioeconomic impact, develop future global research leaders, create advanced tech spinout companies and high value-added jobs for Birmingham and the West Midlands region. Its establishment aligns perfectly with our 2030 strategy that positions Aston University as a leading university of science, technology and enterprise.” Steven Heales, Policy Manager (Innovation) at the West Midlands Combined Authority, said: “WMCA is delighted to see Research England back the Aston Institute for Membrane Excellence. This will enable Aston University’s excellent academics and research community to work closely with businesses to make advances in membrane technology and applications. “In 2023 the West Midlands Combined Authority agreed a Deeper Devolution Trailblazer Deal with Government, which included a new strategic innovation partnership with Government. Projects like AIME are exactly the kind of impact we expect this new partnership to generate, so watch this space.” Lisa Smith, chief executive of Midlands Mindforge, the patient capital investment company formed by eight Midlands research-intensive universities including Aston University, said: “This grant is an important vote of confidence in the Midlands scientific R&D ecosystem. AIME will play an important role in the future research of pioneering breakthroughs in membrane science and enable the world-leading research team at Aston University to develop solutions to real world problems. We look forward to closely working with the Institute and nurturing best-in-field research being undertaken at Aston out of the lab and into the wider society so it can make a positive impact”. Rob Valentine, regional director of Bruntwood SciTech, the UK’s leading developer of city-wide innovation ecosystems and specialist environments and a strategic partner in Birmingham Innovation Quarter, said: "As a proud supporter of the Aston Institute for Membrane Excellence (AIME), I am thrilled at the launch of this groundbreaking initiative. AIME exemplifies Aston University's commitment to advancing cutting-edge interdisciplinary research and further raises the profile of the region’s exemplary research capabilities and sector specialisms. AIME's vision of becoming a 'one-stop shop' for translational membrane research, strategically located at the heart of the country, aligns perfectly with our strategy at Bruntwood SciTech. We are committed to working with partners, including Aston University, to develop a globally significant innovation district at the heart of the UK where the brightest minds and most inspiring spaces will foster tomorrow’s innovation.” Membrane research at Aston University has also recently received two other grants. In November 2023, Professor Bill received £196,648 from the Biotechnology and Biological Sciences Research Council’s Pioneer Awards Scheme to understand how tiny membrane water channels in brain cells keep brains healthy. In December 2023, a team led by AIME team-member Dr Derry received £165,999 from the Engineering and Physical Sciences Research Council to develop biomimetic membranes for water purification. For more information about AIME, visit the webpage.
Aston University scientists to tackle challenges of converting rice straw into biofuels Researchers to examine issues that hinder conversion into an alternative fuel Will help protect global food security, minimise CO2 emissions and decrease farmland needed for growing energy crops. Aston University scientists are to tackle some of the challenges of how to make inedible rice straw into the next generation of biofuels. In recent years, biofuels and biobased chemicals have been blended with petrol to create a more sustainable alternative. The Aston University researchers are to examine issues that currently hinder the conversion of rice straw into an alternative fuel. Currently the production of biofuels mainly relies on sugar crops such as sugarcane and sugar beet, which raises major concern about the competition between growing crops for food or fuel. However plant dry matter such as rice straw is seen as a better alternative to current crops because it doesn’t affect food security. Rice straw is often treated as an agricultural waste by-product and is removed by burning in the field. Farmers burn straw to prepare to plough and sow rice credit: S.Narongrit99 The research is being led by Dr Alfred Fernandez-Castane, senior lecturer in biochemical engineering and principal investigator at the Energy and Bioproducts Research Institute (EBRI) at Aston University, alongside a Marie Curie fellow, Dr Longinus Igbojionu. Their two-year project, An integrated approach to ethanol production from rice straw via microwave-assisted deep eutectic solvent pretreatment and sequential cultivation using Candida tropicalis and Saccharomyces cerevisiae, will explore cleaner and cost effective methods to extract rice straw’s energy-containing molecules. Dr Alfred Fernandez-Castane said: “The problems envisaged with the conversion of rice straw to ethanol can be categorised into four main challenges and resolving each challenge will lead to a major advance on the current state of the art. “The first is to develop pre-treatment conditions which will break down complex polymers thereby allowing the removal of lignin. “The next is to investigate novel biomass pre-treatment technologies combining green solvents and microwaves and how different methods affect morphology, structure and crystallinity of biomass. The next is to develop novel biotrasnformations using the yeasts Candida tropicalis and Saccharomyces cerevisiae to convert sugars into ethanol efficiently. “These three challenges will lead to the fourth scientific challenge which is to make the process sustainable and scalable, such as recycling the wastewater created and even the possibility of using the by-product of yeast for animal feeds.” The team believes that the research will help contribute to combating global warming and decreasing avoidable deaths by protecting global food security, minimising CO2 emissions by reducing the burning of straw and decreasing the farmland needed for growing energy crops. The research will end in November 2025.
• Contaminated water is responsible for around 500,000 deaths a year • New transmembrane proteins will allow selective removal of single contaminant from water • Will use tiny transport channels around one million times smaller than an ant. Aston University scientists are to explore a more sustainable method of separating contaminants from water. The method will use exquisite molecular selectivity, which means that just a single chemical or molecular species will be able to pass through the membrane, allowing scientists to selectively remove a single contaminant from water. The World Health Organization estimates that microbiologically contaminated water is responsible for almost 500,000 deaths a year and current filtration technologies aren’t effective enough. The University has received a grant of £165,999 from the Engineering and Physical Sciences Research Council to research the use of bioinspired membranes to selectively remove contaminants from water, while using minimal energy. The membranes will be made from plastic but will have transmembrane proteins embedded within them, made possible thanks to new polymers developed by the University. The transmembrane proteins enable the selective removal of specific contaminants using transport channels measuring approximately 4-10 nanometres - around one million times smaller than an ant. The Aston University team led by Dr Matt Derry, lecturer in chemistry, will be developing bio-inspired membranes which selectively remove contaminants with minimal energy. Working with Dr Alan Goddard, reader in biochemistry at Aston University, the team’s design is based on solutions found in biological evolution and refinement which has occurred over millions of years. Dr Derry, who is based in the University’s College of Engineering and Physical Sciences. said: “Polluted water is a complex global socioeconomic issue that affects human and animal health, and greatly impacts industries such as agriculture and fishing, recreational activities and transport. “Current filtration technologies are ineffective and their manufacture often requires complex and expensive multi-step processes with high associated energy costs. “We are going to use advanced polymer synthesis to develop new bespoke polymers which will both extract transmembrane proteins and immobilise them within artificial separation membranes. “This will create water purification membranes which remove impurities with greater selectivity and specificity.” The new membrane technology developed in this project will advance and evolve membrane science. The platform materials and approaches used can be applied to other membrane filtration and water purification applications such as selective phosphate removal from agricultural wastewater. Dr Derry added: “We are hoping that the new membranes will lead to high-performance devices that can contribute to a circular economy. “The need for such new systems is recognised by the UN with Sustainable Development Goal six on clean water and sanitation.” The research will begin in April 2024 and will end in May 2026.
SME innovation through the lens of ancient myths - public lecture
Professor Nicholas Theodorakopoulos will explore the transformation in the perception of SMEs since the 1970s He will explain the significance of theory-driven design and delivery of interventions for building the capacity of SMEs to innovate The lecture will take place on Thursday 18 January 2024 at Aston Business School from 1800 hrs. Aston University entrepreneurship expert, Professor Nicholas Theodorakopoulos, will be giving his inaugural lecture at Aston Business School on Thursday 18 January 2024. In his talk SME Innovation, Theory-Driven Intervention, and Ancient Myths Professor Theodorakopoulos will explore the transformation in the perception of SMEs, from being viewed as an anachronism in the 1970s to becoming the driving engine of innovation and a prominent feature of public policy worldwide. Professor Theodorakopoulos will explore the significance of theory-driven design and delivery of interventions for building the capacity of SMEs to innovate and will explain that these are not just academic pursuits, but essential tools for developing replicable and impactful intervention programmes on a national and international scale. He will also present a compelling example of a successful intervention that he has run with colleagues for almost a decade in the West Midlands region. Professor Theodorakopoulos said: “The paradigm shift in SME perception necessitates a robust approach to fostering effective SME development ecosystems, not least through Research and Innovation policies. “A critical component of this policy domain lies in strengthening collaboration and knowledge exchange between universities and SMEs, often achieved through targeted interventions. “I look forward to drawing upon an ancient myth as a metaphor for the significance of knowing not just ‘what works’, but also ‘how it works’, in university-SME interventions.” The lecture is open to the public and free to attend in person or online. The in person event will be followed by a drinks reception. To book your place, click here.